Time to seizure occurrence and damage in PROFILE, a multi-ethnic systemic lupus erythematosus cohort

Lupus

Volumn 17, Issue 3, 2008, Pages 177-184

  Ramsey Goldman, Rosalind ^a   Alarcon G S ^b,c   McGwin, G ^c   Petri, M ^d   Vila L M ^e   Edberg, J C ^b   Reveille, J D ^f   Kimberly, R P ^b  

^a NORTHWESTERN UNIVERSITY   (United States)

^b and Clinical Center   (United States)

^c UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^d JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^e UNIVERSITY OF PUERTO RICO   (Puerto Rico)

^f UNIVERSITY OF TEXAS MEDICAL SCHOOL   (United States)

Author keywords

Lupus; PROFILE; Seizures

Indexed keywords

ADULT; AFRICAN AMERICAN; AGE; ALLELE; ARTICLE; CEREBROVASCULAR ACCIDENT; CLINICAL FEATURE; COHORT ANALYSIS; CONFIDENCE INTERVAL; DEMOGRAPHY; EUROPEAN AMERICAN; FCG3B GENE; FCGR2A GENE; FCGR3A GENE; FEMALE; GENDER; GENE; HEREDITY; HIGH RISK POPULATION; HISPANIC; HLA DQB1 GENE; HLA DRB1 GENE; HUMAN; INCIDENCE; MAJOR CLINICAL STUDY; MALE; PHOTOSENSITIVITY; PREDICTION; PREVALENCE; PRIORITY JOURNAL; PROPORTIONAL HAZARDS MODEL; PSYCHOSIS; RISK ASSESSMENT; RISK FACTOR; SEIZURE; SOCIOECONOMICS; SYSTEMIC LUPUS ERYTHEMATOSUS; UNITED STATES;

ADULT; COHORT STUDIES; FEMALE; HUMANS; LUPUS ERYTHEMATOSUS, SYSTEMIC; MALE; MIDDLE AGED; RISK FACTORS; SEIZURES; TIME FACTORS;

EID: 42549135449     PISSN: 09612033     EISSN: None     Source Type: Journal    
DOI: 10.1177/0961203307086639     Document Type: Article

References (28)

1. Ainiala, H, Hietaharju, A, Loukkola, J, et al. Validity of the new American College of Rheumatology criteria for neuropsychiatric lupus syndromes: a population-based evaluation. Arthritis Rheum 2001; 45: 419-423.
2. Brey, RL, Holliday, SL, Saklad, AR, et al. Neuropsychiatric syndromes in lupus: prevalence using standardized definitions. Neurology 2002; 58: 1214-1220.
3. Hanly, JG, McCurdy, G, Fougere, L, Douglas, JA, Thompson, K. Neuropsychiatric events in systemic lupus erythematosus: attribution and clinical significance. J Rheumatol 2004; 31: 2156-2162.
4. Sanna, G, Bertolaccini, ML, Cuadrado, MJ, et al. Neuropsychiatric manifestations in systemic lupus erythematosus: prevalence and association with antiphospholipid antibodies. J Rheumatol 2003; 30: 985-992.
5. Sibbitt, WL, Brandt, JR, Johnson, CR, et al. The incidence and prevalence of neuropsychiatric syndromes in pediatric onset systemic lupus erythematosus. J Rheumatol 2002; 29: 1536-1542.
6. Hanly, JG, Urowitz, MB, Sanchez-Guerrero, J, et al. Neuropsychiatric events at the time of diagnosis of systemic lupus erythematosus: an international inception cohort study. Arthritis Rheum 2007; 56: 265-273.
7. Mikdashi, J, Krumholz, A, Handwerger, B. Factors at diagnosis predict subsequent occurrence of seizures in systemic lupus erythematosus. Neurology 2005; 64: 2102-2107.
8. Appenzeller, S, Cendes, F, Costallat, LT. Epileptic seizures in systemic lupus erythematosus. Neurology 2004; 63: 1808-1812.
9. Nath, SK, Kilpatrick, J, Harley, JB. Genetics of human systemic lupus erythematosus: the emerging picture. Curr Opin Immunol 2004; 16: 794-800.
10. Croker, JA, Kimberly, RP. SLE: challenges and candidates in human disease. Trends Immunol 2005; 26: 580-586.
11. Croker, JA, Kimberly, RP. Genetics of susceptibility and severity in systemic lupus erythematosus. Curr Opin Rheumatol 2005; 17: 529-537.
12. Graham, RR, Kozyrev, SV, Baechler, EC, et al. A common haplotype of interferon regulatory factor 5 (IRF5) regulates splicing and expression and is associated with increased risk of systemic lupus erythematosus. Nat Genet 2006; 38: 550-555.
13. Alarcón, GS, McGwin, G, Petri, M, et al. Time to renal disease and end-stage renal disease in PROFILE: a multiethnic lupus cohort. PLoS Med 2006; 3: e396.
14. Turnbull, J, Lohi, H, Kearney, JA, et al. Sacred disease secrets revealed: the genetics of human epilepsy. Hum Mol Genet 2005; 14: 2491-2500.
15. Ferraro, TN, Dlugos, DJ, Buono, RJ. Role of genetics in the diagnosis and treatment of epilepsy. Expert Rev Neurother 2006; 6: 1789-1800.
16. Berkovic, SF, Harkin, L, McMahon, JM, et al. De-novo mutations of the sodium channel gene SCN1A in alleged vaccine encephalopathy: a retrospective study. Lancet Neurol 2006; 5: 488-492.
17. Alarcón, GS, McGwin, G, Petri, M, Reveille, JD, Ramsey-Goldman, R, Kimberly, RP. Baseline characteristics of a multiethnic lupus cohort: PROFILE. Lupus 2002; 11: 95-101.
18. Hochberg, MC. Updating the American College of Rheumatology revised criteria for the classifcation of systemic lupus erythematosus. Arthritis Rheum 1998; 41: 751.
19. Tan, EM, Cohen, AS, Fries, JF, et al. The 1982 revised criteria for the classification of SLE. Arthritis Rheum 1982; 25: 1271-1277.
20. Gladman, DD, Goldsmith, CH, Urowitz, MB, et al. The Systemic Lupus International Collaborating Clinics/American College of Rheumatology (SLICC/ACR) damage index for systemic lupus erythematosus international comparison. J Rheumatol 2000; 27: 373-376.
21. Hochberg, M. Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 1997; 40: 1725.
22. Gladman, DD, Ginzler, E, Goldsmith, C, et al. The development and initial validation of the SLICC/ACR damage index for SLE. Arthritis Rheum 1996; 39: 363-369.
23. Reveille, JD, Durban, E, MacLeod-St Clair, MJ, et al. Association of amino acid sequences in the HLA-DQB1 first domain with antitopoisomerase I autoantibody response in scleroderma (progressive systemic sclerosis). J Clin Invest 1992; 90: 973-980.
24. Marsh, SG, Bodmer, JG. HLA class II region nucleotide sequences, 1995. Tissue Antigens 1995; 46: 258-280.
25. Edberg, JC, Langefeld, CD, Wu, J, et al. Genetic linkage and association of Fcgamma receptor IIIA (CD16A) on chromosome 1q23 with human systemic lupus erythematosus. Arthritis Rheum 2002; 46: 2132-2140.
26. Brooks, K, Fessler, B, Bastian, H, Alarcón, G. Sociocultural issues in clinical research. Arthritis Care Res 2001; 45: 203-207.
27. Gladman, DD, Goldsmith, CH, Urowitz, MB, et al. Sensitivity to change of 3 Systemic Lupus Erythematosus Disease Activity Indices: international validation. J Rheumatol 1994; 21: 1468-1471.
28. Liang, MH, Socher, SA, Larson, MG, Schur, PH. Reliability and validity of six systems for the clinical assessment of disease activity in systemic lupus erythematosus. Arthritis Rheum 1989; 32: 1107-1118.